AP / San Francisco Chronicle Examines criticisms that Gilead has not done enough to HIV / AIDS medicines in developing countriesThe AP / San Francisco Chronicle on Sunday examined how is Gilead successful with his antiretroviral drug Truvada ‘not isolated[ the companies] of complaints that it does not doing enough to[ HIV / AIDS] fight, where it hit the hardest, ‘namely, developing countries. AP AP / Chronicle, Gilead ‘recognized’that there is an duty to have his medications available in developing countries. In developing countries effects of lipitor . The company nearly three years ago began the Gilead Access Program, antiretroviral drugs improve access to antiretroviral drugs in developing countries. But say some HIV / AIDS advocates of the program at an ’empty promises ‘, the AP / Chronicle is reported provide. Jilead CEO John Martin said that the company has the opportunity to have their drugs approved by the governments of developing countries must be specified. He added that Gilead believe intellectual property rights worldwide. ‘We are a small company in a big world where billions of dollars are made with the problem of AIDS,’Martin said, adding: ‘Most importantly, we believe that our product should be patented ‘.
The Washington Post investigated on Wednesday his work ‘could fundamentally alter the methodology of philanthropy ‘when he finished his duties at the Bill & Melinda devote more time to the Bill & Melinda Gates Foundation (Noguchi, Washington Post, Gates announced last week, to give in the next two years all daily duties at Microsoft, which he co-founded, and work full-time for the Foundation, issued the still more than $ 10 billion for programs to fight HIV / AIDS and other global to to reform education. Gates said he does not the foundation, but to run the foundation, but a similar role in his work, for his current at Microsoft have (Kaiser Daily HIV / AIDS Report, According to the Post, observers believe that ‘can only goals to be able to clarify ‘the barriers the Foundation is in global health projects such as the development of an HIV vaccine ‘requir[e] political diplomacy, organizational efficiency , and monetary and human resources., challenges that Gates may be uniquely positioned. Political unrest as one of the most successful and driven entrepreneurs era disparate group of governments, other[ not-for-profit] groups and companies that did not respond ‘after the post gates to work with a will,”to ‘disease, mosquitoes, ignorance, and political unrest, ‘the Post reports combat While the Gates Foundation has helped linked fund drug and vaccine development for diseases such as malaria and tuberculosis, problems with the distribution of vaccines. Including a lack of political will and infrastructure – may impede delivery in countries where resources are most needed, according to Adel Mahmoud, incoming CEO of the Global HIV Vaccine Enterprise (Washington Post.
side effects from lipitor
‘courtesy It can use the entire Kaiser Daily Health Policy Report indicate J.earch the archives , or sign up for email service at Imperial Daily Health policy coverage strongly committed emperor network. A free service of of The Henry J. Released. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.